Shopping Cart
- Remove All
Your shopping cart is currently empty
ABT-639 is a potent and selective T-type calcium channel blocker.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $30 | In Stock | |
| 5 mg | $44 | In Stock | |
| 10 mg | $73 | In Stock | |
| 25 mg | $172 | In Stock | |
| 50 mg | $297 | In Stock | |
| 100 mg | $493 | In Stock | |
| 200 mg | $718 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $58 | In Stock |
| Description | ABT-639 is a potent and selective T-type calcium channel blocker. |
| In vitro | ABT-639 is significantly less active at other Ca2+ channels (e.g. Cav1.2 and Cav2.2) (IC50 > 30 μM). ABT-639 has high oral bioavailability (%F = 73), low protein binding (88.9%) and a low brain:plasma ratio (0.05:1) in rodents. |
| In vivo | Following oral administration ABT-639 produces dose-dependent antinociception in a rat model of knee joint pain (ED50 = 2 mg/kg, p.o.). ABT-639 (10-100 mg/kg, p.o.) also increases tactile allodynia thresholds in multiple models of neuropathic pain. The antinociceptive profile of ABT-639 provides novel insights into the role of peripheral T-type (Cav3.2) channels in chronic pain states. |
| Synonyms | ABT 639 |
| Molecular Weight | 455.91 |
| Formula | C20H20ClF2N3O3S |
| Cas No. | 1235560-28-7 |
| Smiles | [H][C@]12CCCN1CCN(C2)C(=O)c1cc(c(F)cc1Cl)S(=O)(=O)Nc1ccccc1F |
| Relative Density. | 1.51 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (120.64 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.